Astera Labs, Inc. Common Stock
Here’s whether Astera Labs, Inc. Common Stock (ALAB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+7.65% over 10 days); strong 1-year return of +139.6%; 3-month momentum positive (+37.0%). Concerns: below the 50-day MA (medium-term momentum negative); RSI 23 — oversold; declining volume on rally — weak conviction (0.76x 30d avg). Currently 41.6% off its 52-week high. Score: +2/7.
ALAB is holding above its long-term 200-day MA ($205.87) but has slipped below the 50-day MA ($350.04), pointing to short-term weakness in an otherwise intact trend. An RSI of 23.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +139.6% compares to +16.5% for SPY (beat the market by 123.2%). The current 41.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.